Deciphering Long Covid: Next Emergent Healthcare Dilemma

##plugins.themes.bootstrap3.article.main##

  •   Sana Abbas

  •   Beenish Abbas

  •   Haifsa Rafique

  •   Aisha Rafique

  •   Saima Zafar

  •   Ramesha Azam

Abstract

Objective: To determine the prevalence of Long Haul COVID–19 Syndrome among Pakistani Population.


Methods: This cross-sectional analytical study was conducted after approval from the ethical review committee of the Foundation University College of Dentistry, Islamabad from June 2021 to September 2021. A non-probability consecutive sampling methodology was employed and a total of (168) participants after voluntary consent were enrolled in the study, after explaining the study protocol to the patients. The final Questionnaire is comprised of three sections. Section – I focused on the demographic profile (Age, Gender, Profession) of the participants. Section – II was designed to investigate COVID – 19 disease history, comorbid, coronavirus disease severity along with the number of individuals infected in the family, duration of positive polymerase chain reaction results, and management destination (Hospital or Home). Section – III addressed the frequency of persistent symptoms (Gastrointestinal, Systemic, Cardiovascular, Musculoskeletal, Immunological, Dermatological, Neuropsychiatric, Ophthalmological, Pulmonary, Otorhinolaryngological, Endocrine, Reproductive and Genitourinary systems).


Results: 168 responders participated in this survey study,48 (28.6%) males while 120 (71.4%) females. About 36 (11.9%) were found to be suffering from comorbidity, 84 (50.0%) suffered from mild disease symptoms, while only 4 (2.4%) experienced the severe disease. The disease was managed at home for a major chunk of responders, 140 (83.3%).132 (78.6%) were found to have suffered from long COVID syndrome with the persistence of symptoms beyond four weeks of infection. The most common symptoms included fatigue (78.8%), fever (60.0%), loss of taste (57.8%), dry cough (45.5%), headache (42.4%), post-exertional malaise (45.5%), shortness of breath (39.4%), insomnia (39.0%), loss of smell (36.4%), loss of appetite (33.3%) and depression (33.3%).Male gender (p=0.009), with existing chronic illnesses (p<0.001), moderate and severe disease (p<0.001), higher age group (p<0.001) and isolated at hospital (p=0.002).


Conclusion: In conclusion, this study has shown that persistence of COVID disease symptoms (most common symptoms included fatigue, fever, loss of taste, dry cough, headache, post-exertional malaise, shortness of breath, insomnia, loss of smell, loss of appetite, and depression) are common in Pakistani population. Male gender, existing chronic illnesses, moderate and severe disease, higher age group, and isolation at the hospital are the probable risk factors.


Keywords: COVID-19, long, symptoms

References

Taribagil P, Creer D, Tahir H. ‘Long COVID’ syndrome. BMJ Case Rep. 2021;14(4): e241485.

Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J. R. Soc. Med. 2021; 0(0): 1–15.

Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS One. 2021; 16(7): e0254523.

Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, 2020. MMWR. 2020; 69(30): 993–8.

Carvalho SC, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021; 27(2): 258-263.

Callard F, Perego E. How and why patients made long Covid. Soc Sci Med. 2021; 268: 113426.

Yelin D, Margalit I, Yahav D, Runold M, Bruchfeld J. Long COVID-19 it’s not over until. Clin Microbiol Infect. 2021; 27(4): 506–508.

Becker RC. COVID-19 and its sequelae: a platform for optimal patient care, discovery, and training. J Thromb Thrombolysis. 2021; 51(3): 587-594.

Halpin S, O'Connor R, Sivan M. Long COVID, and chronic COVID syndromes. J Med Virol. 2021; 93(3): 1242-1243.

Garg M, Maralakunte M, Garg S, Dhooria S, Sehgal I, Bhalla AS et al. The conundrum of ‘Long-COVID-19ʹ: a narrative review. Int J Gen Med. 2021; 14: 2491-2506.

Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. E Clinical Medicine. 2020: 101019.

Baig AM. Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. 2020; 11(24): 4017-4020.

Mahase E. Long covid could be four different syndromes, the review suggests. BMJ. 2020; 371: m3981.

The Lancet. Facing up to long COVID. Lancet. 2020; 396(10266): 1861.

Nabavi N. Long covid: How to define it and how to manage it. BMJ. 2020; 370: m3489.

Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-covid and how should we manage it? Lung. 2021; 199(2): 113-119.

Halpin S, O'Connor R, Sivan M. Long COVID, and chronic COVID syndromes. J Med Virol. 2021; 93(3): 1242-1243.

Butler MJ, Barrientos RM. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav Immun. 2020; 87: 53-54.

Iwu CJ, Iwu CD, Wiysonge CS. The occurrence of long COVID: a rapid review. Pan Afr Med J. 2021; 38:65.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Abbas, S., Abbas, B., Rafique, H., Rafique, A., Zafar, S., & Azam, R. (2021). Deciphering Long Covid: Next Emergent Healthcare Dilemma. European Journal of Medical and Health Sciences, 3(6), 39–43. https://doi.org/10.24018/ejmed.2021.3.6.1096

Most read articles by the same author(s)